CLINICAL_TRIALS
trial_result
· 2013-01-04
Clinical Trial Update: Intracoronary Abciximab With Clearway Catheter [Phase 3]
Summary
A Phase 3 study of intracoronary abciximab with the Clearway catheter for acute myocardial infarction has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gennaro Sardella | Conditions: Acute Myocardial Infarction | Phase 3 | Status: TERMINATED